PLASMODIUM VIVAX INFECTION
Clinical trials for PLASMODIUM VIVAX INFECTION explained in plain language.
Never miss a new study
Get alerted when new PLASMODIUM VIVAX INFECTION trials appear
Sign up with your email to follow new studies for PLASMODIUM VIVAX INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test shot to block recurring malaria
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing an experimental vaccine designed to protect adults from getting malaria caused by the Plasmodium vivax parasite. Seventy-two healthy adults will receive either the vaccine or a placebo shot. Later, they will be deliberately exposed to malaria-carrying mosqui…
Matched conditions: PLASMODIUM VIVAX INFECTION
Phase: PHASE2 • Sponsor: Malaria Vaccine and Drug Development Center • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:38 UTC
-
A phase II clinical study to assess the safety, immunogenicity, and efficacy of blood-stage plasmodium vivax malaria vaccine candidate PvRII/Matrix-M in healthy thai adults living in thailand
Not yet recruitingThis project is the third part of a 5-year research program entitled "Malaria Infection Studies in Thailand (MIST)" and known as MIST3. MIST3's primary objectives are to assess the safety of the PvRII/Matrix-M vaccine candidate in healthy adult Thai volunteers and to establish wh…
Matched conditions: PLASMODIUM VIVAX INFECTION
Phase: PHASE2 • Sponsor: University of Oxford
Last updated Mar 30, 2026 14:32 UTC